, 2023-01-20 16:30:00,
DUBLIN, Jan. 20, 2023 /PRNewswire/ — The “North America Laboratory Animal Diets Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Diet Type, Animal, Application, and End User” report has been added to ResearchAndMarkets.com’s offering.
The laboratory animal diets market in North America is expected to grow from US$ 1,719.20 million in 2022 to US$ 2,304.19 million by 2028; it is estimated to grow at a CAGR of 5.0% from 2022 to 2028.
Rising Use of Mice Models in Virology and Infectious Disease Studies Boost North America Laboratory Animal Diets Market Growth
Mice models are essential tools for studying the pathogenesis of infectious diseases and for the preclinical evaluation of vaccines and therapies against various human pathogens. The use of genetically defined inbred mouse strains, humanized mice, and gene knockout mice has enabled the research community to study pathogens that cause diseases and explain the role of specific host genes in controlling or promoting diseases.
It also helps determine potential targets for the prevention or identification of treatments for various infectious agents. With the growing incidences of new infectious diseases, the animal model has become a vital tool for studying disease mechanisms and developing therapeutics. Mice with xenografted human immune systems have been used to study the pathogenesis of various infectious agents, including Plasmodium falciparum (malaria), Mycobacterium tuberculosis, dengue virus, and…
To read the original article from news.google.com, Click here